Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning

被引:8
|
作者
Bai, Zhixun [1 ,2 ]
Lu, Jing [3 ]
Chen, Anjian [4 ]
Zheng, Xiang [5 ]
Wu, Mingsong [5 ]
Tan, Zhouke [1 ,2 ]
Xie, Jian [5 ]
机构
[1] Zunyi Med Univ, Affiliated Hosp, Organ Transplant Ctr, Zunyi 563006, Peoples R China
[2] Zunyi Med Univ, Affiliated Hosp, Dept Nephrol, Zunyi 563006, Peoples R China
[3] Zunyi Med & Pharmaceut Coll, Dept Clin, Zunyi 563000, Peoples R China
[4] Zunyi Med Univ, Affiliated Hosp, Dept Urol, Zunyi 563006, Peoples R China
[5] Zunyi Med Univ, Dept Med Genet, Zunyi 563006, Peoples R China
基金
中国国家自然科学基金;
关键词
ccRCC; lncRNA; cuproptosis; immunotherapy; TMB score; GLIOMA PROGRESSION; AXIS; PROMOTE; MODEL;
D O I
10.3390/biom12121890
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
(1) Objective: We aimed to mine cuproptosis-related LncRNAs with prognostic value and construct a corresponding prognostic model using machine learning. External validation of the model was performed in the ICGC database and in multiple renal cancer cell lines via qPCR. (2) Methods: TCGA and ICGC cohorts related to renal clear cell carcinoma were included. GO and KEGG analyses were conducted to determine the biological significance of differentially expressed cuproptosis-related LncRNAs (CRLRs). Machine learning (LASSO), Kaplan-Meier, and Cox analyses were conducted to determine the prognostic genes. The tumor microenvironment and tumor mutation load were further studied. TIDE and IC50 were used to evaluate the response to immunotherapy, a risk model of LncRNAs related to the cuproptosis genes was established, and the ability of this model was verified in an external independent ICGC cohort. LncRNAs were identified in normal HK-2 cells and verified in four renal cell lines via qPCR. (3) Results: We obtained 280 CRLRs and identified 66 LncRNAs included in the TCGA-KIRC cohort. Then, three hub LncRNAs (AC026401.3, FOXD2-AS1, and LASTR), which were over-expressed in the four ccRCC cell lines compared with the human renal cortex proximal tubule epithelial cell line HK-2, were identified. In the ICGC database, the expression of FOXD2-AS1 and LASTR was consistent with the qPCR and TCGA-KIRC. The results also indicated that patients with low-risk ccRCC-stratified by tumor-node metastasis stage, sex, and tumor grade-had significantly better overall survival than those with high-risk ccRCC. The predictive algorithm showed that, according to the three CRLR models, the low-risk group was more sensitive to nine target drugs (A.443654, A.770041, ABT.888, AG.014699, AMG.706, ATRA, AP.24534, axitinib, and AZ628), based on the estimated half-maximal inhibitory concentrations. In contrast, the high-risk group was more sensitive to ABT.263 and AKT inhibitors VIII and AS601245. Using the CRLR models, the correlation between the tumor immune microenvironment and cancer immunotherapy response revealed that high-risk patients are more likely to respond to immunotherapy than low-risk patients. In terms of immune marker levels, there were significant differences between the high- and low-risk groups. A high TMB score in the high-risk CRLR group was associated with worse survival, which could be a prognostic factor for KIRC. (4) Conclusions: This study elucidates the core cuproptosis-related LncRNAs, FOXD2-AS1, AC026401.3, and LASTR, in terms of potential predictive value, immunotherapeutic strategy, and outcome of ccRCC.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
    Huili, Youlong
    Nie, Shiwen
    Zhang, Liguo
    Yao, Anliang
    Liu, Jian
    Wang, Yong
    Wang, Lei
    Cao, Fenghong
    [J]. FRONTIERS IN GENETICS, 2022, 13
  • [2] Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
    Xu, Qiu-Shuang
    Shen, Zheng-Zhong
    Yuan, Ling-Qing
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [3] Validation and identification of anoikis-related lncRNA signatures for improving prognosis in clear cell renal cell carcinoma
    Zhu, Zhenjie
    Wang, Qibo
    Zeng, Xiaowei
    Zhu, Shaoxing
    Chen, Jinchao
    [J]. AGING-US, 2024, 16 (04): : 3915 - 3933
  • [4] Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma
    Xie, Tongjin
    Liu, Bin
    Liu, Dongbo
    Zhou, Yusong
    Yang, Qingping
    Wang, Dai
    Tang, Mengjie
    Liu, Wei
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [5] A Cuproptosis-Related Gene Model For Predicting the Prognosis of Clear Cell Renal Cell Carcinoma
    Mei, Wangli
    Liu, Xiang
    Jia, Xuyang
    Jin, Liang
    Xin, Shiyong
    Sun, Xianchao
    Zhang, Jiaxin
    Zhang, Bihui
    Chen, Yilai
    Che, Jianping
    Ma, Weiguo
    Ye, Lin
    [J]. FRONTIERS IN GENETICS, 2022, 13
  • [6] Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma
    Pang, Yipeng
    Wang, Yushi
    Zhou, Xinyu
    Ni, Zhu
    Chen, Wenjing
    Liu, Yi
    Du, Wenlong
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)
  • [7] Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma
    Shen, Junlin
    Wang, Linhui
    Bi, Jianbin
    [J]. BMC CANCER, 2023, 23 (01)
  • [8] Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma
    Junlin Shen
    Linhui Wang
    Jianbin Bi
    [J]. BMC Cancer, 23
  • [9] A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma
    Xin, Sheng
    Mao, Jiaquan
    Cui, Kai
    Li, Qian
    Chen, Liang
    Li, Qinyu
    Tu, Bocheng
    Liu, Xiaming
    Wang, Tao
    Wang, Shaogang
    Liu, Jihong
    Song, Xiaodong
    Song, Wen
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [10] Cuproptosis-Related Ferroptosis genes for Predicting Prognosis in kidney renal clear cell carcinoma
    Luo, Gang
    Wang, Lini
    Zheng, Ziyu
    Gao, Baobao
    Lei, Chong
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)